The Trump administration is set to announce new findings related to autism today. Reports indicate that officials will discuss potential links between acetaminophen, the active ingredient in Tylenol, and an increased risk of autism in children when taken during early pregnancy.

Sources, who spoke on the condition of anonymity, revealed that the administration will address concerns regarding the use of acetaminophen and its possible association with autism. However, Kenvue, the manufacturer of Tylenol, has denied any connection between its product and autism. The company maintains that acetaminophen does not cause autism.

In addition to discussing the potential risks, the administration is expected to present a new drug that it believes could treat autism. This announcement comes amid ongoing debates about autism research and treatment options.

White House Press Secretary Karoline Leavitt will hold a briefing at 1 p.m. ET to outline President Donald Trump’s agenda. Later in the day, Trump is scheduled to speak about autism research at 4 p.m. ET from the Roosevelt Room at the White House.